In our study, IL‐33 upregulated the expression of PI3K and AKT proteins in ILC2s through ST2, increasing the levels of IL‐5 and IL‐13 (Th2 cytokines) and aggravating lung inflammation in patients with EA. The gene discussed is AKT1; the disease is Esophageal atresia.